ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies

Review

C P Engelfriet et al. Baillieres Clin Haematol. 1990 Apr.

. 1990 Apr;3(2):321-37.

doi: 10.1016/s0950-3536(05)80053-8.

No abstract available

Similar articles

Critical evaluation of the ADCC test.
Brojer E, Górska B. Brojer E, et al. Arch Immunol Ther Exp (Warsz). 1986;34(2):231-8. Arch Immunol Ther Exp (Warsz). 1986. PMID: 3098206
ADCC activity of monoclonal anti-D antibodies.
Urbaniak SJ, Stewart GM. Urbaniak SJ, et al. Rev Fr Transfus Immunohematol. 1988 Apr;31(2):237-43. doi: 10.1016/s0338-4535(88)80109-0. Rev Fr Transfus Immunohematol. 1988. PMID: 3145551 No abstract available.
Predicting the clinical significance of red cell antibodies with in vitro cellular assays.
Garratty G. Garratty G. Transfus Med Rev. 1990 Oct;4(4):297-312. doi: 10.1016/s0887-7963(90)70272-6. Transfus Med Rev. 1990. PMID: 2134635 Review. No abstract available.
Rosetting, phagocytosis and immune red cell damage.
Zupańska B. Zupańska B. Clin Lab Haematol. 1990;12(3):309-20. doi: 10.1111/j.1365-2257.1990.tb00041.x. Clin Lab Haematol. 1990. PMID: 2125543 Review.
ADCC lysis of human erythrocytes sensitized with rhesus alloantibodies. IV. Characterization of anti-D sera which are inactive in ADCC.
Barclay GR, Forouhi P, McCann MC, Greiss MA, Urbaniak SJ. Barclay GR, et al. Br J Haematol. 1985 Jun;60(2):293-304. doi: 10.1111/j.1365-2141.1985.tb07415.x. Br J Haematol. 1985. PMID: 2408657